Complement inhibition in severe COVID-19 - Blocking C5a seems to be key.

Lim, Endry H T; Vlaar, Alexander P J; de-Bruin, Sanne; Brouwer, Matthijs C; van-de-Beek, Diederik

Lim, Endry H T; Vlaar, Alexander P J; de-Bruin, Sanne; Brouwer, Matthijs C; van-de-Beek, Diederik.

Lim EHT; Department of Intensive Care Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam UMC, 1100DD Amsterdam, the Netherlands.
Vlaar APJ; Department of Intensive Care Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam UMC, 1100DD Amsterdam, the Netherlands.
de-Bruin S; Department of Intensive Care Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam UMC, 1100DD Amsterdam, the Netherlands.
Brouwer MC; Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
van-de-Beek D; Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

EClinicalMedicine ; 35: 100722, 2021 May.

Article in English | MEDLINE | ID: covidwho-1201234

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: EClinicalMedicine Year: 2021 Document Type: Article Affiliation country: J.eclinm.2021.100722

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google